Literature DB >> 12296863

X-chromosome inactivation analysis in a female carrier of FOXP3 mutation.

A Tommasini1, S Ferrari, D Moratto, R Badolato, M Boniotto, D Pirulli, L D Notarangelo, M Andolina.   

Abstract

Immune dysregulation, polyendocrinopathy and enteropathy with X-linked inheritance (IPEX) is a serious disease arising from mutations in FOXP3. This gene codifies for a transcription factor whose dysfunction results in hyperactivation of T cells. It is not clear, however, why an intermediate phenotype is not seen in heterozygous females, who are completely healthy. In order to address this question, we investigated X-chromosome inactivation in peripheral blood lymphocytes from a heterozygous female with a child affected by IPEX. No preferential inactivation was shown in freshly sorted CD4+, CD8+, CD19+ cells or in IL-2 cultured CD4 and CD8 T cells, indicating that peripheral blood lymphocytes in these women are randomly selected. Moreover, only one single FOXP3 transcript was expressed by CD4 T cell clones analysed by RT-PCR, confirming that this gene is subject to X- inactivation. We hypothesize that hyper-activation of T cell in carriers of FOXP3 mutations is regulated by the presence of normal regulatory T cells.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12296863      PMCID: PMC1906506          DOI: 10.1046/j.1365-2249.2002.01940.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  18 in total

1.  Thymic selection of CD4+CD25+ regulatory T cells induced by an agonist self-peptide.

Authors:  M S Jordan; A Boesteanu; A J Reed; A L Petrone; A E Holenbeck; M A Lerman; A Naji; A J Caton
Journal:  Nat Immunol       Date:  2001-04       Impact factor: 25.606

2.  Treatment of the immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome (IPEX) by allogeneic bone marrow transplantation.

Authors:  O Baud; O Goulet; D Canioni; F Le Deist; I Radford; D Rieu; S Dupuis-Girod; N Cerf-Bensussan; M Cavazzana-Calvo; N Brousse; A Fischer; J L Casanova
Journal:  N Engl J Med       Date:  2001-06-07       Impact factor: 91.245

3.  Escape from tolerance in the human X-linked autoimmunity-allergic disregulation syndrome and the Scurfy mouse.

Authors:  D D Patel
Journal:  J Clin Invest       Date:  2001-01       Impact factor: 14.808

Review 4.  IPEX is a unique X-linked syndrome characterized by immune dysfunction, polyendocrinopathy, enteropathy, and a variety of autoimmune phenomena.

Authors:  C L Bennett; H D Ochs
Journal:  Curr Opin Pediatr       Date:  2001-12       Impact factor: 2.856

5.  Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction.

Authors:  P Chomczynski; N Sacchi
Journal:  Anal Biochem       Date:  1987-04       Impact factor: 3.365

6.  Fatal lymphoreticular disease in the scurfy (sf) mouse requires T cells that mature in a sf thymic environment: potential model for thymic education.

Authors:  V L Godfrey; J E Wilkinson; E M Rinchik; L B Russell
Journal:  Proc Natl Acad Sci U S A       Date:  1991-07-01       Impact factor: 11.205

7.  Disruption of a new forkhead/winged-helix protein, scurfin, results in the fatal lymphoproliferative disorder of the scurfy mouse.

Authors:  M E Brunkow; E W Jeffery; K A Hjerrild; B Paeper; L B Clark; S A Yasayko; J E Wilkinson; D Galas; S F Ziegler; F Ramsdell
Journal:  Nat Genet       Date:  2001-01       Impact factor: 38.330

8.  Increased susceptibility of a carrier of X-linked chronic granulomatous disease (CGD) to Aspergillus fumigatus infection associated with age-related skewing of lyonization.

Authors:  A Rösen-Wolff; W Soldan; K Heyne; J Bickhardt; M Gahr; J Roesler
Journal:  Ann Hematol       Date:  2001-02       Impact factor: 3.673

9.  Scurfin (FOXP3) acts as a repressor of transcription and regulates T cell activation.

Authors:  L A Schubert; E Jeffery; Y Zhang; F Ramsdell; S F Ziegler
Journal:  J Biol Chem       Date:  2001-08-01       Impact factor: 5.157

10.  Human cd25(+)cd4(+) t regulatory cells suppress naive and memory T cell proliferation and can be expanded in vitro without loss of function.

Authors:  M K Levings; R Sangregorio; M G Roncarolo
Journal:  J Exp Med       Date:  2001-06-04       Impact factor: 14.307

View more
  22 in total

1.  X-linked tumor suppressors: perplexing inheritance, a unique therapeutic opportunity.

Authors:  Yang Liu; Lizhong Wang; Pan Zheng
Journal:  Trends Genet       Date:  2010-04-29       Impact factor: 11.639

Review 2.  CD4+ Tregs and immune control.

Authors:  Zoltán Fehérvari; Shimon Sakaguchi
Journal:  J Clin Invest       Date:  2004-11       Impact factor: 14.808

Review 3.  Regulatory T cell-mediated transplantation tolerance.

Authors:  Ankit Bharat; Ryan Courtney Fields; T Mohanakumar
Journal:  Immunol Res       Date:  2005       Impact factor: 2.829

4.  Novel pathogenic variants in FOXP3 in fetuses with echogenic bowel and skin desquamation identified by ultrasound.

Authors:  Raymond J Louie; Queenie K-G Tan; Jennifer B Gilner; R Curtis Rogers; Noelle Younge; Stephanie B Wechsler; Marie T McDonald; Barbara Gordon; Christopher A Saski; Julie R Jones; Shelley J Chapman; Roger E Stevenson; John W Sleasman; Michael J Friez
Journal:  Am J Med Genet A       Date:  2017-03-20       Impact factor: 2.802

5.  Inverse correlation between CD4+ regulatory T-cell population and autoantibody levels in paediatric patients with systemic lupus erythematosus.

Authors:  Jyh-Hong Lee; Li-Chieh Wang; Yu-Tsan Lin; Yao-Hsu Yang; Dong-Tsamn Lin; Bor-Luen Chiang
Journal:  Immunology       Date:  2006-02       Impact factor: 7.397

6.  Splice variants of human FOXP3 are functional inhibitors of human CD4+ T-cell activation.

Authors:  Emma L Smith; Helene M Finney; Andrew M Nesbitt; Fred Ramsdell; Martyn K Robinson
Journal:  Immunology       Date:  2006-10       Impact factor: 7.397

7.  Rescue of the autoimmune scurfy mouse by partial bone marrow transplantation or by injection with T-enriched splenocytes.

Authors:  S K Smyk-Pearson; A C Bakke; P K Held; R S Wildin
Journal:  Clin Exp Immunol       Date:  2003-08       Impact factor: 4.330

8.  The clinical utility of molecular diagnostic testing for primary immune deficiency disorders: a case based review.

Authors:  Rohan Ameratunga; See-Tarn Woon; Katherine Neas; Donald R Love
Journal:  Allergy Asthma Clin Immunol       Date:  2010-06-08       Impact factor: 3.406

9.  Development of Foxp3(+) regulatory t cells is driven by the c-Rel enhanceosome.

Authors:  Qingguo Ruan; Vasumathi Kameswaran; Yukiko Tone; Li Li; Hsiou-Chi Liou; Mark I Greene; Masahide Tone; Youhai H Chen
Journal:  Immunity       Date:  2009-12-18       Impact factor: 31.745

10.  Activating transcription factor 2 and c-Jun-mediated induction of FoxP3 for experimental therapy of mammary tumor in the mouse.

Authors:  Yan Liu; Yin Wang; Weiquan Li; Pan Zheng; Yang Liu
Journal:  Cancer Res       Date:  2009-07-07       Impact factor: 12.701

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.